|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eder M and Scherr M: MicroRNA and lung
cancer. N Engl J Med. 352:2446–2448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scott GK, Goga A, Bhaumik D, Berger CE,
Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3
by enforced expression of micro-RNA miR-125a or miR-125b. J Biol
Chem. 282:1479–1486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar
|
|
6
|
Goldstraw P, Crowley J, Chansky K, et al:
The IASLC Lung Cancer Staging Project: proposals for the revision
of the TNM stage groupings in the forthcoming (seventh) edition of
the TNM Classification of Malignant Tumours. J Thorac Oncol.
2:706–714. 2007. View Article : Google Scholar
|
|
7
|
Govindan R, Page N, Morgensztern D, et al:
Changing epidemiology of small-cell lung cancer in the United
States over the last 30 years: analysis of the surveillance,
epidemiologic, and end results database. J Clin Oncol.
24:4539–4544. 2006.PubMed/NCBI
|
|
8
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu SL, Chen HY, Chang GC, et al: MicroRNA
signature predicts survival and relapse in lung cancer. Cancer
Cell. 13:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raponi M, Dossey L, Jatkoe T, et al:
MicroRNA classifiers for predicting prognosis of squamous cell lung
cancer. Cancer Res. 69:5776–5783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soomro IN, Holmes J and Whimster WF:
Predicting prognosis in lung cancer: use of proliferation marker,
Ki67 monoclonal antibody. J Pak Med Assoc. 48:66–69.
1998.PubMed/NCBI
|
|
12
|
Tiscornia G and Izpisua Belmonte JC:
MicroRNAs in embryonic stem cell function and fate. Genes Dev.
24:2732–2741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Monzo M, Navarro A, Bandres E, et al:
Overlapping expression of microRNAs in human embryonic colon and
colorectal cancer. Cell Res. 18:823–833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scholzen T and Gerdes J: The Ki-67
protein: from the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takahashi S, Kamata Y, Tamo W, et al:
Relationship between postoperative recurrence and expression of
cyclin E, p27, and Ki-67 in non-small cell lung cancer without
lymph node metastases. Int J Clin Oncol. 7:349–355. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martin B, Paesmans M, Mascaux C, et al:
Ki-67 expression and patients survival in lung cancer: systematic
review of the literature with meta-analysis. Br J Cancer.
91:2018–2025. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Woo T, Okudela K, Yazawa T, et al:
Prognostic value of KRAS mutations and Ki-67 expression in stage I
lung adenocarcinomas. Lung Cancer. 65:355–362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Watanabe A, Tagawa H, Yamashita J, et al:
The role of microRNA-150 as a tumor suppressor in malignant
lymphoma. Leukemia. 25:1324–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma Y, Zhang P, Wang F, et al: miR-150 as a
potential biomarker associated with prognosis and therapeutic
outcome in colorectal cancer. Gut. 61:1447–1453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Toyooka S, Matsuo K, Shigematsu H, et al:
The impact of sex and smoking status on the mutational spectrum of
epidermal growth factor receptor gene in non-small cell lung
cancer. Clin Cancer Res. 13:5763–5768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Izzotti A, Calin GA, Arrigo P, Steele VE,
Croce CM and De Flora S: Downregulation of microRNA expression in
the lungs of rats exposed to cigarette smoke. FASEB J. 23:806–812.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao JY, Ma LM, Guo YH, et al: Deep
sequencing of human nuclear and cytoplasmic small RNAs reveals an
unexpectedly complex subcellular distribution of miRNAs and tRNA 3′
trailers. PLoS One. 5:e105632010.PubMed/NCBI
|
|
23
|
Persson H, Kvist A, Rego N, et al:
Identification of new microRNAs in paired normal and tumor breast
tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res.
71:78–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Starzynska T, Bromley M, Ghosh A and Stern
PL: Prognostic significance of p53 overexpression in gastric and
colorectal carcinoma. Br J Cancer. 66:558–562. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Andersen TI, Holm R, Nesland JM, Heimdal
KR, Ottestad L and Borresen AL: Prognostic significance of TP53
alterations in breast carcinoma. Br J Cancer. 68:540–548. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chava S, Mohan V, Shetty PJ, et al:
Immunohistochemical evaluation of p53, FHIT, and IGF2 gene
expression in esophageal cancer. Dis Esophagus. 25:81–87. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamakuchi M, Ferlito M and Lowenstein CJ:
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci
USA. 105:13421–13426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park SY, Lee JH, Ha M, Nam JW and Kim VN:
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat
Struct Mol Biol. 16:23–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou BP, Liao Y, Xia W, Zou Y, Spohn B and
Hung MC: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2
phosphorylation. Nat Cell Biol. 3:973–982. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fornari F, Gramantieri L, Giovannini C, et
al: MiR-122/cyclin G1 interaction modulates p53 activity and
affects doxorubicin sensitivity of human hepatocarcinoma cells.
Cancer Res. 69:5761–5767. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Laurent LC, Chen J, Ulitsky I, et al:
Comprehensive microRNA profiling reveals a unique human embryonic
stem cell signature dominated by a single seed sequence. Stem
Cells. 26:1506–1516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ren J, Jin P, Wang E, Marincola FM and
Stroncek DF: MicroRNA and gene expression patterns in the
differentiation of human embryonic stem cells. J Transl Med.
7:202009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao C, Sun G, Li S, et al: MicroRNA
let-7b regulates neural stem cell proliferation and differentiation
by targeting nuclear receptor TLX signaling. Proc Natl Acad Sci
USA. 107:1876–1881. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Melton C, Judson RL and Blelloch R:
Opposing microRNA families regulate self-renewal in mouse embryonic
stem cells. Nature. 463:621–626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu F, Yao H, Zhu P, et al: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
